New obesity drug data has this Ozempic rival moving

🇺🇸 Election Open House ALL week!                                                                                                                                                                                                                                                                                                                                                                                                                 November 04, 2024 | [Read Online]( 🇺🇸 Election Open House ALL week! *Together with Monument Trader’s Alliance & CompareCredit Good day, 360! This week we have a special invitation to join Election Trading ALL week. These guys are pros so [register to join MTA’s War Room]([Happening NOW!]. Be the best prepared trader on the Street! FOCUS LIST🔎 CTM - Up over 30% in the pre-market after reporting better than expected earnings SYTA - Up over 20% in pre after announcing it has secured new $2.5 million order VKTX - Up over 9% in pre after reporting new data from VK2735 Obesity Program at ObesityWeek® 2024 *Together with Monument Trader’s Alliance Reminder: MTA’s Election Open House Starts Today! What Is It? One week inside MTA’s War Room - totally free! When Is It? November 4 – 8 (Election Week - starts TODAY) What You’ll Get: FREE Live Trades… FREE Training… FREE Post Election Livestream Trading Event You're Invited! [Register here for a one-week FREE PREVIEW]( (no credit card, no BS) HOTLIST🔥 CTM - Up over 30% in the pre-market after reporting better than expected earnings Castellum (CTM) Inc. provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. In the pre-market this morning, the [company announced]( certain highlights of its operating results for its third quarter ended September 30, 2024. Highlights include: Revenue for the third quarter of 2024 was $11.6 million, up sequentially from $11.5 million and $11.3 million during the second and first quarters of 2024, respectively.  Gross profit was $5.0 million compared to $4.7 million and $4.5 million during the second and first quarters of 2024, respectively. Shares of CTM traded up over 30% in the pre-market in reaction to the results. The $0.1550 area was a prior support and will be an important level to watch. Above it, targets to the upside are $0.18, $0.20, $0.2160 and then the pre-market high at $0.2271. Beyond that, $0.24, $0.27 and $0.29 come into play. Bellow $0.1550, targets to the downside are a gap fill at $0.1423 with $0.13 and $0.1216 below that. SYTA - Up over 20% in pre after announcing it has secured new $2.5 million order Siyata Mobile Inc. (SYTA) is a global vendor of Push-to-Talk over Cellular ("PoC") devices and cellular signal booster systems. In the pre-market this morning, the [company announced]( it has received an order valued at $2.5 million for its PTT handsets as well its Real Time View devices from an existing customer, an international EMS organization. The Company expects to deliver the order in the first quarter of 2025. Shares of SYTA traded up over 20$ in the pre-market in reaction to the news. The $1.15 was a prior support area and will be an important level to watch. Above it, targets to the upside are $1.24, $1.36 and then $1.39. Above that the pre-market high at $1.46 comes into play. Below $1.15, targets to the downside are $1.11, $1.06, $1 and then $0.93. VKTX - Up over 9% in pre after reporting new data from VK2735 Obesity Program at ObesityWeek® 2024 Viking Therapeutics Inc. (VKTX) is a clinical-stage biopharmaceutical company that focuses on the development of novel therapies for metabolic and endocrine disorders. In the pre-market this morning, the [company announced]( new data from VK2735 Obesity Program at ObesityWeek® 2024. Highlights Include: Up to 6.8% Placebo-Adjusted Mean Weight Loss (8.2% from Baseline) After 28 Days of Dosing with Oral Tablet of VK2735 Encouraging Tolerability Through 100 mg Daily Dosing with Oral VK2735; Mild GI-Related Adverse Event Profile Updated Results from VENTURE Phase 2 Study of Subcutaneous VK2735 Show Durable Effects and Support Potential Monthly Dosing Regimen Shares of VKTX traded up over 9% in the pre-market in reaction to the news. The $75.50 area acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $79, $80, $82, $83.79 and then the pre-market high at $91.71. Below $75.50, there is a gap to fill at $72.88 with $70.50 below that. *Sponsored by CompareCredit 2 Cards Charging 0% Interest Until 2026 Paying down your credit card balance can be tough with the majority of your payment going to interest. Avoid interest charges for up to 18 months with these cards. [Learn more]( MARKET NEWS 📰 P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. *Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America [Terms of Service](